BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26758533)

  • 1. Anticancer Potential and Molecular Targets of Pristimerin: A Mini- Review.
    Yousef BA; Hassan HM; Zhang LY; Jiang ZZ
    Curr Cancer Drug Targets; 2017; 17(2):100-108. PubMed ID: 26758533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pristimerin exhibits in vitro and in vivo anticancer activities through inhibition of nuclear factor-кB signaling pathway in colorectal cancer cells.
    Yousef BA; Hassan HM; Zhang LY; Jiang ZZ
    Phytomedicine; 2018 Feb; 40():140-147. PubMed ID: 29496166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
    Yousef BA; Guerram M; Hassan HM; Hamdi AM; Zhang LY; Jiang ZZ
    Oncol Rep; 2016 Feb; 35(2):1091-100. PubMed ID: 26718323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer activity of pristimerin in epidermal growth factor receptor 2-positive SKBR3 human breast cancer cells.
    Lee JS; Yoon IS; Lee MS; Cha EY; Thuong PT; Diep TT; Kim JR
    Biol Pharm Bull; 2013; 36(2):316-25. PubMed ID: 23370361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo.
    Tiedemann RE; Schmidt J; Keats JJ; Shi CX; Zhu YX; Palmer SE; Mao X; Schimmer AD; Stewart AK
    Blood; 2009 Apr; 113(17):4027-37. PubMed ID: 19096011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pristimerin inhibits breast cancer cell migration by up- regulating regulator of G protein signaling 4 expression.
    Mu XM; Shi W; Sun LX; Li H; Wang YR; Jiang ZZ; Zhang LY
    Asian Pac J Cancer Prev; 2012; 13(4):1097-104. PubMed ID: 22799288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells.
    Yousef BA; Hassan HM; Guerram M; Hamdi AM; Wang B; Zhang LY; Jiang ZZ
    Biomed Pharmacother; 2016 Apr; 79():112-9. PubMed ID: 27044819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pristimerin, a naturally occurring triterpenoid, attenuates tumorigenesis in experimental colitis-associated colon cancer.
    Park JH; Kim JK
    Phytomedicine; 2018 Mar; 42():164-171. PubMed ID: 29655682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pristimerin, a natural anti-tumor triterpenoid, inhibits LPS-induced TNF-α and IL-8 production through down-regulation of ROS-related classical NF-κB pathway in THP-1 cells.
    Hui B; Yao X; Zhou Q; Wu Z; Sheng P; Zhang L
    Int Immunopharmacol; 2014 Aug; 21(2):501-8. PubMed ID: 24957686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pristimerin Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review.
    Sun J; Tian Z; Wu J; Li J; Wang Q; Huang S; Wang M
    Drug Des Devel Ther; 2024; 18():1673-1694. PubMed ID: 38779590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative activity of pristimerin isolated from Maytenus ilicifolia (Celastraceae) in human HL-60 cells.
    Costa PM; Ferreira PM; Bolzani Vda S; Furlan M; de Freitas Formenton Macedo Dos Santos VA; Corsino J; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Pessoa C
    Toxicol In Vitro; 2008 Jun; 22(4):854-63. PubMed ID: 18296021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells.
    Yang H; Landis-Piwowar KR; Lu D; Yuan P; Li L; Reddy GP; Yuan X; Dou QP
    J Cell Biochem; 2008 Jan; 103(1):234-44. PubMed ID: 17541980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pristimerin Induces Autophagy-Mediated Cell Death in K562 Cells through the ROS/JNK Signaling Pathway.
    Liu Y; Ren Z; Li X; Zhong J; Bi Y; Li R; Zhao Q; Yu X
    Chem Biodivers; 2019 Aug; 16(8):e1900325. PubMed ID: 31290253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of pristimerin in ovarian carcinoma cells is mediated through the inhibition of prosurvival Akt/NF-κB/mTOR signaling.
    Gao X; Liu Y; Deeb D; Arbab AS; Gautam SC
    J Exp Ther Oncol; 2014; 10(4):275-83. PubMed ID: 25509983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triterpenoids as new promising anticancer drugs.
    Petronelli A; Pannitteri G; Testa U
    Anticancer Drugs; 2009 Nov; 20(10):880-92. PubMed ID: 19745720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF‑κB pathway.
    Zhang B; Zhang J; Pan J
    Int J Oncol; 2017 Sep; 51(3):887-898. PubMed ID: 28766683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction.
    Guo Y; Zhang W; Yan YY; Ma CG; Wang X; Wang C; Zhao JL
    J BUON; 2013; 18(2):477-85. PubMed ID: 23818365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, Characterization and Anticancer Potential of Cytotoxic Triterpenes from Betula utilis Bark.
    Mishra T; Arya RK; Meena S; Joshi P; Pal M; Meena B; Upreti DK; Rana TS; Datta D
    PLoS One; 2016; 11(7):e0159430. PubMed ID: 27453990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pristimerin Inhibits LPS-Triggered Neurotoxicity in BV-2 Microglia Cells Through Modulating IRAK1/TRAF6/TAK1-Mediated NF-κB and AP-1 Signaling Pathways In Vitro.
    Hui B; Zhang L; Zhou Q; Hui L
    Neurotox Res; 2018 Feb; 33(2):268-283. PubMed ID: 29119451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.